Compile Data Set for Download or QSAR
Found 175 with Last Name = 'tojo' and Initial = 't'
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50513317(CHEMBL4465620)copy SMILEScopy InChI
Affinity DataKi:  68nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3QJRPubMed
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50513318(CHEMBL4516553)copy SMILEScopy InChI
Affinity DataKi:  470nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3QJRPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50435711(CHEMBL2392121)copy SMILEScopy InChI
Affinity DataIC50: 5.10nMAssay Description:Inhibition of rat VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured aft...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427008(CHEMBL2326864)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:Inhibition of rat VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured aft...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427008(CHEMBL2326864)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50435712(CHEMBL2390968)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:Inhibition of rat VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured aft...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433263(CHEMBL2376162)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50435711(CHEMBL2392121)copy SMILEScopy InChI
Affinity DataIC50: 19nMAssay Description:Inhibition of human VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433257(CHEMBL2376160 | CHEMBL2376161)copy SMILEScopy InChI
Affinity DataIC50: 20nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433266(CHEMBL2376169)copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433263(CHEMBL2376162)copy SMILEScopy InChI
Affinity DataIC50: 36nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433258(CHEMBL2376166)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433259(CHEMBL2375367)copy SMILEScopy InChI
Affinity DataIC50: 53nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433257(CHEMBL2376160 | CHEMBL2376161)copy SMILEScopy InChI
Affinity DataIC50: 72nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433261(CHEMBL2376164)copy SMILEScopy InChI
Affinity DataIC50: 92nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433259(CHEMBL2375367)copy SMILEScopy InChI
Affinity DataIC50: 120nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50435707(CHEMBL2392120)copy SMILEScopy InChI
Affinity DataIC50: 150nMAssay Description:Inhibition of rat VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured aft...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433258(CHEMBL2376166)copy SMILEScopy InChI
Affinity DataIC50: 150nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433261(CHEMBL2376164)copy SMILEScopy InChI
Affinity DataIC50: 160nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433262(CHEMBL2376163)copy SMILEScopy InChI
Affinity DataIC50: 210nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427008(CHEMBL2326864)copy SMILEScopy InChI
Affinity DataIC50: 230nMAssay Description:Inhibition of human VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427008(CHEMBL2326864)copy SMILEScopy InChI
Affinity DataIC50: 230nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50151585(CHEMBL3774476)copy SMILEScopy InChI
Affinity DataIC50: 280nMAssay Description:Inhibition of full length N-terminal His-tagged human recombinant LSD1 (1 to 852 residues) expressed in Escherichia coli BL21(DE3) cells using H3K4me...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3P22PubMed
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50151584(CHEMBL3775613)copy SMILEScopy InChI
Affinity DataIC50: 290nMAssay Description:Inhibition of full length N-terminal His-tagged human recombinant LSD1 (1 to 852 residues) expressed in Escherichia coli BL21(DE3) cells using H3K4me...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3P22PubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433262(CHEMBL2376163)copy SMILEScopy InChI
Affinity DataIC50: 300nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50148781(CHEMBL3770903)copy SMILEScopy InChI
Affinity DataIC50: 300nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50513317(CHEMBL4465620)copy SMILEScopy InChI
Affinity DataIC50: 310nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3QJRPubMed
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50151583(CHEMBL3774920)copy SMILEScopy InChI
Affinity DataIC50: 320nMAssay Description:Inhibition of full length N-terminal His-tagged human recombinant LSD1 (1 to 852 residues) expressed in Escherichia coli BL21(DE3) cells using H3K4me...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3P22PubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433260(CHEMBL2376165)copy SMILEScopy InChI
Affinity DataIC50: 320nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427009(CHEMBL2326875)copy SMILEScopy InChI
Affinity DataIC50: 330nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50513320(CHEMBL4471909)copy SMILEScopy InChI
Affinity DataIC50: 370nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3QJRPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433267(CHEMBL2376168)copy SMILEScopy InChI
Affinity DataIC50: 390nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50435706(CHEMBL2392118)copy SMILEScopy InChI
Affinity DataIC50: 420nMAssay Description:Inhibition of rat VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured aft...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50151587(CHEMBL3774486)copy SMILEScopy InChI
Affinity DataIC50: 440nMAssay Description:Inhibition of full length N-terminal His-tagged human recombinant LSD1 (1 to 852 residues) expressed in Escherichia coli BL21(DE3) cells using H3K4me...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3P22PubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433260(CHEMBL2376165)copy SMILEScopy InChI
Affinity DataIC50: 450nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427014(CHEMBL2326870)copy SMILEScopy InChI
Affinity DataIC50: 520nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50513318(CHEMBL4516553)copy SMILEScopy InChI
Affinity DataIC50: 600nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3QJRPubMed
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50151588(CHEMBL3775735)copy SMILEScopy InChI
Affinity DataIC50: 610nMAssay Description:Inhibition of full length N-terminal His-tagged human recombinant LSD1 (1 to 852 residues) expressed in Escherichia coli BL21(DE3) cells using H3K4me...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3P22PubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427022(CHEMBL2326861)copy SMILEScopy InChI
Affinity DataIC50: 680nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427019(CHEMBL2326865)copy SMILEScopy InChI
Affinity DataIC50: 730nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433265(CHEMBL2376170)copy SMILEScopy InChI
Affinity DataIC50: 850nMAssay Description:Inhibition of rat VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after 1...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50435710(CHEMBL2392117)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of rat VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured aft...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Rattus norvegicus (Rat))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM7960(1H-1,3-benzodiazol-2-amine | 2-Aminobenzimidazole ...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of rat VAP-1 expressed in CHO cells using [14C]-benzylamine as substrate preincubated for 30 mins prior to substrate addition measured aft...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22B90DGPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433265(CHEMBL2376170)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427024(CHEMBL2326859)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50427021(CHEMBL2326862)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K64KDWPubMed
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50513319(CHEMBL4589851)copy SMILEScopy InChI
Affinity DataIC50: 1.18E+3nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JH3QJRPubMed
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50392111(CHEMBL2152613)copy SMILEScopy InChI
Affinity DataIC50: 1.74E+3nMAssay Description:Inhibition of human N-terminal His-tagged SIRT2 expressed in Escherichia coli using p53 (Gln-Pro-Lys-Lys(Ac)) (317 to 320 residues) as substrate incu...More data for this Ligand-Target Pair
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Kyoto Prefectural University of Medicine

Curated by ChEMBL
LigandPNGBDBM50095454(CHEMBL3590422)copy SMILEScopy InChI
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of JARID1A (unknown origin) using biotinylated H3K9mel peptide after 60 mins by Alpha screen assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2V69MC7PubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Astellas Pharma Inc.

Curated by ChEMBL
LigandPNGBDBM50433268(CHEMBL2376167)copy SMILEScopy InChI
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of human VAP1 expressed in CHO cells using [14C]-benzylamine as substrate incubated for 30 mins prior to substrate addition measured after...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M046TZPubMed
Displayed 1 to 50 (of 175 total ) | Next | Last >>
Jump to: